{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:51:03Z","timestamp":1783039863448,"version":"3.54.6"},"reference-count":33,"publisher":"Elsevier BV","issue":"41","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,22]],"date-time":"2021-08-22T00:00:00Z","timestamp":1629590400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GSK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003761","name":"UMC Utrecht","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003761","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009248","name":"Innovatiefonds Zorgverzekeraars","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009248","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.vaccine.2021.08.067","type":"journal-article","created":{"date-parts":[[2021,9,7]],"date-time":"2021-09-07T16:29:41Z","timestamp":1631032181000},"page":"6151-6156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of non-specific effects of human rotavirus vaccination in medical risk infants"],"prefix":"10.1016","volume":"39","author":[{"given":"Josephine A.P.","family":"van Dongen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsbeth D.M.","family":"Rouers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc J.M.","family":"Bonten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia C.J.","family":"Bruijning-Verhagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2021.08.067_b0005","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.smim.2018.06.002","article-title":"Non-specific effects of vaccines: current evidence and potential implications","volume":"39","author":"de Bree","year":"2018","journal-title":"Semin Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2021.08.067_b0010","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/ni.2961","article-title":"Nonspecific effects of neonatal and infant vaccination: public-health, immunological and conceptual challenges","volume":"15","author":"Aaby","year":"2014","journal-title":"Nat Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2021.08.067_b0015","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.it.2013.04.004","article-title":"A small jab - a big effect: nonspecific immunomodulation by vaccines","volume":"34","author":"Benn","year":"2013","journal-title":"Trends Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2021.08.067_b0020","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1136\/archdischild-2015-310282","article-title":"Non-specific effects of vaccines: plausible and potentially important, but implications uncertain","volume":"102","author":"Pollard","year":"2017","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.vaccine.2021.08.067_b0025","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1093\/infdis\/jiy069","article-title":"Neonatal BCG vaccination influences cytokine responses to toll-like receptor ligands and heterologous antigens","volume":"217","author":"Freyne","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2021.08.067_b0030","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1093\/infdis\/jiu508","article-title":"Heterologous immunological effects of early BCG vaccination in low-birth-weight infants in Guinea-Bissau: a randomized-controlled trial","volume":"211","author":"Jensen","year":"2015","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2021.08.067_b0035","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.clim.2014.10.005","article-title":"BCG-induced trained immunity in NK cells: role for non-specific protection to infection","volume":"155","author":"Kleinnijenhuis","year":"2014","journal-title":"Clin Immunol"},{"key":"10.1016\/j.vaccine.2021.08.067_b0040","doi-asserted-by":"crossref","first-page":"17537","DOI":"10.1073\/pnas.1202870109","article-title":"Bacille Calmette-Gu\u00e9rin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes","volume":"109","author":"Kleinnijenhuis","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.vaccine.2021.08.067_b0045","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41577-020-0285-6","article-title":"Defining trained immunity and its role in health and disease","volume":"20","author":"Netea","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2021.08.067_b0050","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.cmi.2019.04.020","article-title":"Non-specific effects of BCG vaccine on viral infections","volume":"25","author":"Moorlag","year":"2019","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"10.1016\/j.vaccine.2021.08.067_b0055","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S1473-3099(20)30653-8","article-title":"BCG-induced non-specific effects on heterologous infectious disease in Ugandan neonates: an investigator-blind randomised controlled trial","volume":"21","author":"Prentice","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"nov30 2","key":"10.1016\/j.vaccine.2021.08.067_b0060","doi-asserted-by":"crossref","first-page":"c6495","DOI":"10.1136\/bmj.c6495","article-title":"Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: Randomised controlled trial","volume":"341","author":"Aaby","year":"2010","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.vaccine.2021.08.067_b0065","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1093\/cid\/civ617","article-title":"The effect of oral polio vaccine at birth on infant mortality: a randomized trial","volume":"61","author":"Lund","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"47","key":"10.1016\/j.vaccine.2021.08.067_b0070","doi-asserted-by":"crossref","first-page":"6694","DOI":"10.1016\/j.vaccine.2012.08.055","article-title":"No effect of oral polio vaccine administered at birth on mortality and immune response to BCG: a natural experiment","volume":"30","author":"Lund","year":"2012","journal-title":"Vaccine"},{"issue":"23-24","key":"10.1016\/j.vaccine.2021.08.067_b0075","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1016\/j.vaccine.2004.02.009","article-title":"Oral polio vaccination and low case fatality at the paediatric ward in Bissau, Guinea-Bissau","volume":"22","author":"Aaby","year":"2004","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2021.08.067_b0080","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1067\/mai.2003.171","article-title":"The effect of neonatal BCG vaccination on atopy and asthma at age 7 to 14 years: an historical cohort study in a community with a very low prevalence of tuberculosis infection and a high prevalence of atopic disease","volume":"111","author":"Marks","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2021.08.067_b0085","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1046\/j.1365-2222.2000.00803.x","article-title":"Early BCG vaccination and reduction in atopy in Guinea-Bissau","volume":"30","author":"Aaby","year":"2000","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.vaccine.2021.08.067_b0090","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2222.2007.02859.x","article-title":"Bacille-Calmette-Guerin vaccination and the development of allergic disease in children: a randomized, prospective, single-blind study","volume":"38","author":"Steenhuis","year":"2008","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.vaccine.2021.08.067_b0095","first-page":"1995","article-title":"Inverse association between tuberculin responses and atopic disorder","volume":"51","author":"Hopkin","year":"1996","journal-title":"Thorax"},{"key":"10.1016\/j.vaccine.2021.08.067_b0100","first-page":"355","article-title":"Non-specific immunological effects of selected routine childhood immunisations: systematic review","author":"Kandasamy","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2021.08.067_b0105","first-page":"355","article-title":"Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review","author":"Higgins","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2021.08.067_b0110","unstructured":"Clinicaltrials.gov. BCG and COVID trials 2021. https:\/\/clinicaltrials.gov\/ct2\/results\/map?cond=BCG+vaccine+AND+covid&map= (accessed February 26, 2021)."},{"key":"10.1016\/j.vaccine.2021.08.067_b0115","unstructured":"WHO Meeting of the Strategic Advisory Group of Experts on immunization, October 2017 \u2013 conclusions and recommendations. Wkly Epidemiol Rec 2017;92:301\u201320."},{"key":"10.1016\/j.vaccine.2021.08.067_b0120","doi-asserted-by":"crossref","first-page":"7727","DOI":"10.1038\/s41598-019-44193-4","article-title":"Lower incidence rate of type 1 diabetes after receipt of the rotavirus vaccine in the United States, 2001\u20132017","volume":"9","author":"Rogers","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2021.08.067_b0125","unstructured":"van Dongen JAP, Bruijning-Verhagen PC, Bonten MJ, Team O behalf of the R study. Rotavirus Vaccine Effectiveness among Infants with Medical Risk Conditions in the Netherlands. ESPID Conf 2021;27\/05\/2021:Manuscript under review."},{"key":"10.1016\/j.vaccine.2021.08.067_b0130","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/jpids\/piy029","article-title":"BCG vaccination at birth and rate of hospitalization for infection until 15 months of age in Danish children: a randomized clinical multicenter trial","volume":"8","author":"Stensballe","year":"2019","journal-title":"J Pediatric Infect Dis Soc"},{"key":"10.1016\/j.vaccine.2021.08.067_b0135","article-title":"Bacillus Calmette-Gu\u00e9rin vaccination to prevent COVID-19 in vulnerable elderly: preliminary results of a randomised controlled trial","author":"Koekenbier","year":"2021","journal-title":"ESCMID Conf"},{"key":"10.1016\/j.vaccine.2021.08.067_b0140","first-page":"4","article-title":"Importance of ICD-10 coding directive change for acute gastroenteritis (unspecified) for rotavirus vaccine impact studies: Illustration from a population-based cohort study from Ontario","volume":"8","author":"Wilson","year":"2015","journal-title":"Canada. BMC Res Notes"},{"issue":"2","key":"10.1016\/j.vaccine.2021.08.067_b0145","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1136\/archdischild-2013-305655","article-title":"Does neonatal BCG vaccination prevent allergic disease in later life?","volume":"99","author":"Freyne","year":"2014","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.vaccine.2021.08.067_b0150","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/infdis\/jix612","article-title":"Rapid protective effects of early BCG on neonatal mortality among low birth weight boys: observations from randomized trials","volume":"217","author":"Biering-S\u00f8rensen","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2021.08.067_b0155","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/cid\/cix525","article-title":"Early BCG-Denmark and neonatal mortality among infants weighing <2500 g: a randomized controlled trial","volume":"65","author":"Biering-S\u00f8rensen","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2021.08.067_b0160","doi-asserted-by":"crossref","first-page":"e0224766","DOI":"10.1371\/journal.pone.0224766","article-title":"Risk of infection in the first year of life in preterm children: An Austrian observational study","volume":"14","author":"Steiner","year":"2019","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2021.08.067_b0165","first-page":"1","article-title":"Acute gastroenteritis disease burden in infants with medical risk conditions in the Netherlands","volume":"XX","author":"van Dongen","year":"2020","journal-title":"Pediatr Infect Dis J"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21011154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21011154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:01:23Z","timestamp":1759402883000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21011154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":33,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0264410X21011154"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.08.067","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of non-specific effects of human rotavirus vaccination in medical risk infants","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.08.067","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}